Arch Therapeutics

About:

Arch Therapeutics is a medical device company offering an innovative therapeutic approach to stasis and barrier applications.

Website: http://archtherapeutics.com

Twitter/X: ARTHinc

Description:

Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients.

Total Funding Amount:

$27M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Natick, Massachusetts, United States

Founded Date:

2006-01-01

Founders:

Rutledge Ellis-Behnke, Terrence W. Norchi

Number of Employees:

1-10

Last Funding Date:

2023-09-07

IPO Status:

Public

Industries:

© 2025 bioDAO.ai